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In the 1986 Star Trek ﬁlm The Voyage Home, the U.S.S.
Enterprise crew travels back in time to 20th-century
Earth and visits a contemporary hospital. Struck by the lack
of diagnostic sophistication, the Enterprise’s physician,
Dr. McCoy, provides assistance using a handheld, intelli-
gent “scanner” allowing the noninvasive identiﬁcation of
complex pathology. Although our diagnostic modalities still
fall short of this futuristic vision, high-tech diagnostic im-
aging in research laboratories and tertiary care hospitals in
the richest countries worldwide now has a ﬂair of science
ﬁction. An example with particular interest in cardiovascular
medicine is the so-called vulnerable plaque, deﬁned as an
atherosclerotic lesion at risk for causing (imminent) vascular
events, such as heart attacks and strokes.See page 989The term vulnerable plaque was coined in the 1980s by
Muller et al. (1), who had worked together on understanding
triggers of coronary syndromes. Dr. Muller was at the time 1
of 3 American cofounders of the International Physicians for
the Prevention of Nuclear War, which in 1985 won the
Nobel Peace Prize (1,2). He suggested the use of the term
vulnerable plaque after he had been deeply involved in dis-
cussions about the vulnerability of American nuclear
weapons silos to a Russian surprise attack (Jim Muller,
personal communication). Although many of these war-
heads have since disappeared, vulnerable coronary lesions
have not and in fact are an increasing cause of morbidity and
mortality worldwide. We have learned a lot about these
lesions on the basis of animal models, pathology, and
invasive imaging modalities (3,4), but their noninvasive
identiﬁcation before clinical events is still elusive (5).*Editorials published in the Journal of the American College of Cardiology reﬂect the
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sults from a single-center study investigating the usefulness
of coronary noncontrast T1-weighted (T1W) magnetic
resonance imaging (MRI) for the detection of hyperintense
coronary plaque and its prognostic value. This technique has
been established for carotid imaging and can reliably identify
carotid plaque with intraplaque hemorrhage (7). A recent
meta-analysis of the predictive value of intraplaque hemor-
rhage containing carotid plaque for cerebrovascular events
using T1W MRI demonstrated an annualized event rate of
17.7% in subjects with detectable intraplaque hemorrhage,
compared with 2.4% in those without (8). Prior work by
Noguchi et al. (9) showed that these carotid lesions are also
associated with cardiac events during follow-up. Similar
plaque features have been identiﬁed in coronary arteries
using noncontrast T1W MRI and correlate with computed
tomographic characteristics of vulnerability, as well as a high
incidence of slow-ﬂow phenomena (10–12).
In the present study, the investigators prospectively
included 568 patients with suspected or known coronary
artery disease and examined whether the presence of
hyperintense plaque was associated with increased likelihood
of subsequent coronary events including cardiac death, ST-
segment elevation myocardial infarction, unstable angina
pectoris or non–ST-segment elevation myocardial infarc-
tion, or ischemia-related percutaneous coronary inter-
vention. Noncontrast T1W coronary MRI was used to
determine the plaque-to-myocardium signal intensity ratio
(PMR). Hyperintense plaques were subdivided into those
with PMRs >1.4, PMRs of 1.0 to 1.4, and PMRs <1.0.
During a median follow-up period of 55 months, coronary
events were observed in 55 patients. Patients with PMRs
>1.4 had signiﬁcantly higher likelihood (25.8%) of subse-
quent coronary events compared with those with PMRs
of 1.0 to 1.4 (8.4%) and those with PMRs <1.0 (1.1%).
On receiver-operating characteristic curve analysis, a PMR
of 1.4 was identiﬁed as the optimal cutoff for predicting
prognosis. Multivariate Cox regression analysis identiﬁed
the presence of plaques with PMRs 1.4 as the strongest
independent predictor of coronary events (hazard ratio: 3.96;
95% conﬁdence interval: 1.92 to 8.17; p < 0.001) compared
with the presence of coronary artery disease (hazard ratio:
3.56; 95% conﬁdence interval: 1.76 to 7.20; p < 0.001) and
other traditional risk factors.
These exciting data have some limitations. As described
for carotid data in the meta-analysis cited earlier (8), there is
inhomogeneity of the data; for example, prior studies used
different cutoffs for PMR (12). Therefore, application to
individual patients and comparison of study results is still
limited.
These high-tech imaging modalities, eventually combined
with artiﬁcial intelligence (e.g., the supercomputer Watson,
which successfully ﬁnished medical school in 1 week [13]),
have the potential to advance cardiovascular diagnosis and
would perhaps even impress Dr. McCoy. However, the
immediate value as a clinical tool for individual patients is
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1001still limited. This is because of the technical complexity and
limited access to these high-tech tests, even in the richest
countries. Most important, we currently do not have the
differentiated therapeutic tools to tailor the therapeutic
response for individual patients on the basis of such results,
beyond current standard preventive measures. Global clinical
impact will depend on translation of the insights won with
these high-tech modalities into clinical guidelines and stra-
tegies guiding basic preventive strategies. However, as a
research tool, these modalities have the “mission to explore”
novel diagnostic and therapeutic strategies for cerebrovas-
cular and cardiovascular events and “to seek out” solutions
for current and emergent threats to human health (1,2).
Such research will have primary and also unpredictable
secondary gains in medicine, science, and technology. Sup-
port of such futuristic research initiatives in societies that can
afford scientiﬁc curiosity and innovation is therefore an in-
vestment similar to the national space program in the 1950s
(14), which has, last but not least, inspired the “mission”
statement of the voyages of the starship Enterprise: “to
explore strange new worlds, to seek out new life and new
civilizations, to boldly go where no man has gone before.”
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